Navigation Links
FDA Approves New Treatment for Type 2 Diabetes
Date:5/2/2011

SILVER SPRING, Md., May 2, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Tradjenta (linagliptin) tablets, used with diet and exercise, to improve blood glucose control in adults with Type 2 diabetes.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

People with Type 2 diabetes do not produce or respond normally to insulin, a hormone that regulates the amount of glucose in the blood. Over time, high blood glucose levels can increase the risk for serious complications, including heart disease, blindness, and nerve and kidney damage.

"This approval provides another treatment option for the millions of Americans with Type 2 diabetes," said Mary Parks, M.D., director of the Division of Metabolism and Endocrinology Products in the FDA's Center for Drug Evaluation and Research. "It is effective when used alone or when added to existing treatment regimens."

Type 2 diabetes is the most common form of the disease, affecting between 90 percent and 95 percent of the 24 million people in the United States with diabetes. Tradjenta increases the level of hormones that stimulate the release of insulin after a meal by blocking the enzyme dipeptidyl peptidase-4 or DPP-4, which leads to better blood glucose control.

Tradjenta was demonstrated to be safe and effective in eight double-blind, placebo-controlled clinical studies involving about 3,800 patients with Type 2 diabetes. The studies showed improvement in blood glucose control compared with placebo.

Tradjenta has been studied as a stand-alone therapy and in combination with other Type 2 diabetes therapies including metformin, glimepiride, and pioglitazone. Tradjenta has not been studied in combination with insulin, and should not be used to treat people with Type 1 diabetes or in those who have increased ketones in their blood or urine (diabetic ketoacidosis).

Tradje
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Zytiga for Late-Stage Prostate Cancer
2. FDA Approves Updated, Clarified Indication for Use for iFuse Implant System®
3. FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients
4. FDA Approves the First Vaccine to Prevent Meningococcal Disease in Infants and Toddlers
5. FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis
6. FDA Approves New Medical Device for Form of Brain Cancer
7. FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors
8. FDA Approves Horizant To Treat Restless Legs Syndrome
9. FDA Approves New Treatment for Rare Form of Thyroid Cancer
10. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
11. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... LONDON , March 27, 2015 ... commercial prospects for leading ophthalmic drug companies  ... the pharma ophthalmic industry ? Visiongain,s brand new ... trends, opportunities and prospects there. Our 242-page ... most lucrative areas in the industry and the future ...
(Date:3/27/2015)... , March 27, 2015 ... by Product (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter ... X-ray)) & Indication (AF, VT, WPW) - Global Forecasts ... is expected to reach around ~$4.73 Billion by 2019 ... period 2014 to 2019. Browse   ...
(Date:3/27/2015)... 2015 The International Myeloma Foundation (IMF) – ... working toward prevention and a cure – today commended ... federal resolution (H. Res. 174) that supports the designation ... Myeloma Awareness Month." Currently there are more ... than 110,000 new cases are diagnosed yearly, according to ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... REDWOOD CITY, Calif., Dec. 28 Codexis, Inc. announced today that ... U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial ... of common stock to be sold in this offering are proposed ... , Credit Suisse Securities (USA) LLC and Goldman, Sachs & Co. ...
... , , , , PORTSMOUTH, Va., Dec. 28 ViVre Medical, ... of its new LifeGuard30(TM) medical record systems. These gifts ... as well as to charitable and non-profit organizations. The LifeGuard30(TM) system ... patient information at the scene of a medical emergency without the ...
Cached Medicine Technology:Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering 2ViVre Medical Announces $6,000,000 Gift 2ViVre Medical Announces $6,000,000 Gift 3
(Date:3/28/2015)... March 28, 2015 Emergency Medical Care ... care in Manhattan, recently commemorated its three-year anniversary of ... Manhattan. In addition to 24-hour urgent care, Emergency Medical ... , At this time, Emergency Medical Care’s Urgent ... asthma, chest pain, eye injuries, ear infections, fevers, insect ...
(Date:3/28/2015)... IL (PRWEB) March 28, 2015 Centurion Service ... equipment auction on Thursday, April 2 at their Las Vegas ... Vegas, NV 89081. The sale, which consists of equipment from ... begin promptly at 9 a.m. PDT. , Buyers will ... and surgery equipment. “We are a one-stop-shop,” said Erik Tivin, ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... injuries is a growing field in orthopaedic medicine. While ... labral tear to confirm the pain etiology, research presented ... ( AOSSM ) Specialty Day suggests that pain relief ... following arthroscopic hip surgery. , “Our study looked ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Genomic medicine ... peritoneal mesothelioma, revealing, for the first time, key information ... here to read the newly posted story on ... the University of British Columbia, the British Columbia Cancer ... mapping to reveal underlying molecular alterations and mutations that ...
(Date:3/28/2015)... 28, 2015 Aureus Medical Group ... including physical therapy jobs, has announced that it ... Physical Therapy Association Annual Conference to be held ... Hotel in Columbus, OH. , The OPTA ... exhibits with products and services. , Representatives ...
Breaking Medicine News(10 mins):Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... warning to expectant mothers to completely avoid consuming Vitamin E ... unborn child //. ,A leading obstetrician, Prof Stuart ... warning on Vitamin E following clinical trials that have revealed ... child. It is also known to increase the rates of ...
... to understand and prevent the spread of avian flu //. ... of Department for Food, Environment and Rural Affairs (Defra) Science ... contract and transmit the avian influenza virus has important human ... potential host for avian influenza because of the extensive infection ...
... metabolism, which occurs when the body has difficulty processing ... patients //with chronic nerve dysfunction of unknown cause than ... factor for the condition, according to a study posted ... print issue of Archives of Neurology, one of the ...
... CHICAGO - The number of mutations in a gene previously ... the age at which the condition develops; even individuals who ... Parkinson's disease, according to a report in the June issue ... , ,Parkinson's disease affects about 1 percent of individuals ...
... may be related to a reduced risk of developing ... in the June 12 //issue of Archives of Internal ... ,Cirrhosis progressively destroys healthy liver tissue and replaces it ... can cause cirrhosis, but long-term, heavy alcohol use is ...
... as transcendental meditation may decrease blood pressure and ... heart disease, according to a report in the ... one of the JAMA/Archives journals. , ... in India, is taught through a standard protocol ...
Cached Medicine News:Health News:Abnormal Glucose Metabolism May Contribute to Chronic Nerve Disorder 2Health News:Gene Mutation May Influence Age at Onset of Parkinson's Disease 2Health News:Coffee Drinking Associated with Lower Risk for Alcohol-Related Liver Disease 2Health News:Meditation may Improve Cardiac Risk Factors in Patients with Coronary Heart Disease 2
Scoville Ruptured Disc Curettes, length 10" (254 mm), cup size 4 x 10 mm....
Codmans Micro Osseous Dissection Curette, bayonnet, working distance: 3" (76 mm)....
PG Magnum Ring Curettes, total length 12.6" (32 cm), handle length 7.8" (20 cm), handle diameter 1.12" (3 cm), working distance 4.7" (12 cm), dual-coned, precision sharpened rings....
Karlin XL Magnum Cup Curettes, extra long (XL) curettes, black handles, lightweight, length 13 1/4" (33.7 cm), handle length 8 1/2" (21 cm), handle diameter 1 1/4" (32 cm)....
Medicine Products: